The number of desaturation episodes defined as blood oxygen saturation (SpO2) below 90% during the perioperative period during colonoscopy.
| Group | Value | 95% CI |
|---|---|---|
| The High Flow Nasal Cannula | 0 | 0 – 1 |
| The Standard Nasal Cannula | 0 | 0 – 2 |
Last reviewed · How we verify
High-Flow Nasal Cannula and Desaturation Episodes in the Morbidly Obese Patients
NA trial testing The Comfort Flo system in Desaturation of Blood in 59 participants. Completed in 22 January 2018.
| Lead sponsor | University of Texas Southwestern Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 59 |
| Start date | 10 May 2017 |
| Primary completion | 28 August 2017 |
| Estimated completion | 22 January 2018 |
| Sites | 2 locations across United States |
University of Texas Southwestern Medical Center
Adults 18 to 80, any sex, with Desaturation of Blood or Obesity. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
The number of desaturation episodes defined as blood oxygen saturation (SpO2) below 90% during the perioperative period during colonoscopy.
| Group | Value | 95% CI |
|---|---|---|
| The High Flow Nasal Cannula | 0 | 0 – 1 |
| The Standard Nasal Cannula | 0 | 0 – 2 |
It is standard practice in the United States and many parts of world to perform Gastrointestinal (GI) endoscopy with the patient under deep sedation. Obesity is accepted as a patient specific risk factor for hypoxic events during procedural sedation for GI endoscopic procedures. The Obese population has a higher prevalence of obstructive sleep apnea (OSA) which is characterized by repeated obstruction of the upper airway, and leads to apnea and desaturation. This prospective, randomized study was designed to compare the effectiveness of the high flow nasal cannula and the standard nasal cannula in morbidly obese (BMI \> 40) patients receiving deep intravenous sedation during colonoscopies. This study will assess whether use of the high flow nasal cannula (HFNC) leads to less intraoperative desaturation events compared to the current standard of care.
2 peer-reviewed publications reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03148262.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing